Published on 3 Oct 2021 on Insider Monkey via Yahoo Finance
Is La Jolla Pharmaceutical Company (LJPC) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period that ended June 30th, so let’s proceed with the discussion of the hedge fund sentiment on La Jolla Pharmaceutical Company (NASDAQ:LJPC).
La Jolla Pharmaceutical Company (NASDAQ:LJPC) investors should pay attention to an increase in support from the world's most elite money managers in recent months. La Jolla Pharmaceutical Company (NASDAQ:LJPC) was in 10 hedge funds' portfolios at the end of June. The all time high for this statistic is 21. There were 9 hedge funds in our database with LJPC positions at the end of the first quarter. Our calculations also showed that LJPC isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings).
According to most investors, hedge funds are seen as underperforming, old investment vehicles of the past. While there are greater than 8000 funds in operation today, Our experts hone in on the top tier of this group, approximately 850 funds. It is estimated that this group of investors have their hands on the lion's share of the smart money's total asset base, and by tailing their best equity investments, Insider Monkey has unsheathed several investment strategies that have historically surpassed the S&P 500 index. Insider Monkey's flagship short hedge fund strategy outstripped the S&P 500 short ETFs by around 20 percentage points annually since its inception in March 2017. Also, our monthly newsletter's portfolio of long stock picks returned 185.4% since March 2017 (through August 2021) and beat the S&P 500 Index by more than 79 percentage points. You can download a sample issue of this newsletter on our website .